Downloadable ContentDownload PDF
Carbohydrate - Based Experimental Therapeutics For Cancer, HIV/AIDs And Other Diseases
This review, primarily for general readers, briefly presents experimental approaches to therapeutics of cancer, HIV/AIDS and various other diseases based on advances in glycobiology and glycochemistry. Experimental cancer and HIV/AIDS vaccines are being developed in attempts to overcome weak immunological responses to carbohydrate – rich surface antigens using carriers, adjuvants and novel carbohydrate antigen constructs. Current carbohydrate – based vaccines are used for typhus, pneumonia, meningitis and vaccines for anthrax, malaria and leishmaniasis are under development. The link between O– linked β-N-acetylglucosamine glycosylation and protein phosphorylation in diseases including diabetes and Alzheimer's disease is also explored. Carbohydrate – associated drugs that are in current use or under development such as heparan sulphate binders, lectins, acarbose, aminoglycosides, tamiflu, and heparin, and technologies using carbohydrate and lectin microarrays, that offer improved diagnostic and drug development possibilities, are described. Advances in carbohydrate synthesis, analysis, and manipulation through the emerging fields of glycochemistry and glycobiology, are providing new approaches to disease therapeutics.